A uniform thymic malignant lymphoma model established with C57BL/6 p53 gene deficient mice

Changfa Fan; Jianjun Lyu; Susu Liu; Xi Wu; Qianqian Li; Shuya Zhou; Yanwei Yang; Guitao Huo; Qin Zuo; Qingfen Zhu; Ming Guo; Simei Ren; Yanan Guo; Sanlong Wang; Baowen Li; Xue Wang; Yuelei Shen; Youchun Wang

doi:10.18632/oncotarget.24108

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

A uniform thymic malignant lymphoma model established with C57BL/6 p53 gene deficient mice

Changfa Fan _, Jianjun Lyu, Susu Liu, Xi Wu, Qianqian Li, Shuya Zhou, Yanwei Yang, Guitao Huo, Qin Zuo, Qingfen Zhu, Ming Guo, Simei Ren, Yanan Guo, Sanlong Wang, Baowen Li, Xue Wang, Yuelei Shen and Youchun Wang

Changfa Fan1,*, Jianjun Lyu2,*, Susu Liu1,*, Xi Wu1, Qianqian Li2, Shuya Zhou1, Yanwei Yang2, Guitao Huo2, Qin Zuo1, Qingfen Zhu3, Ming Guo3, Simei Ren4, Yanan Guo5, Sanlong Wang2, Baowen Li1, Xue Wang2, Yuelei Shen5 and Youchun Wang1

1Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Tiantan Xili, Beijing 100050, China

2National Center for Safety Evaluation of Drugs, Institute for Food and Drug Safety Evaluation, National Institutes for Food and Drug Control, Beijing Economic-Technological Development Area, Beijing 100176, China

3Shandong Institute for Food and Drug Control, High-Tech Zone, Jinan 250101, China

4Department of Hematology, National Center for Clinical Laboratories and Beijing Hospital, Beijing 100730, China

5Beijing Biocytogen Co. LTD, Economic-Technological Development Area, Beijing 101111, China

*These authors contributed equally to this work

Correspondence to:

Youchun Wang, email: [email protected]

Keywords: p53 deficient mouse; lymphoma model; MNU induction; C57BL/6 genetic background; T cell lineage

Received: November 01, 2016 Accepted: December 03, 2017 Published: January 02, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24108

Publication Alerts

Withdrawal Notice

Research Papers:

A uniform thymic malignant lymphoma model established with C57BL/6 p53 gene deficient mice